0001562180-16-003141.txt : 20160914
0001562180-16-003141.hdr.sgml : 20160914
20160914091416
ACCESSION NUMBER: 0001562180-16-003141
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160912
FILED AS OF DATE: 20160914
DATE AS OF CHANGE: 20160914
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dermira, Inc.
CENTRAL INDEX KEY: 0001557883
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273267680
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 275 MIDDLEFIELD ROAD
STREET 2: SUITE 150
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650 421 7200
MAIL ADDRESS:
STREET 1: 275 MIDDLEFIELD ROAD
STREET 2: SUITE 150
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GUGGENHIME ANDREW
CENTRAL INDEX KEY: 0001230724
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36668
FILM NUMBER: 161884282
MAIL ADDRESS:
STREET 1: 3061 ZANKER RD
CITY: SAN JOSE
STATE: CA
ZIP: 95134
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2016-09-12
false
0001557883
Dermira, Inc.
DERM
0001230724
GUGGENHIME ANDREW
C/O DERMIRA, INC.
275 MIDDLEFIELD ROAD, SUITE 150
MENLO PARK
CA
94025
false
true
false
false
COO and CFO
Common Stock
2016-09-12
4
M
false
10000.00
5.51
A
15116.00
D
Common Stock
2016-09-12
4
S
false
10000.00
32.53
D
5116.00
D
Employee Stock Options (Right to buy)
5.51
2016-09-12
4
M
false
10000.00
0.00
D
2024-06-04
Common Stock
10000.00
150513.00
D
These trades were made pursuant to a Rule 10b5-1 trading plan.
This transaction was executed in multiple trades at prices ranging from $32.30 to $32.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
These shares include prior ESPP purchases.
25% of the total shares underlying the option vested and became exercisable on May 1, 2015 and 1/48 of the total shares underlying the option vest and become exercisable each month thereafter, subject to the continuing employment of the Reporting person on the applicable vesting date.
/s/ Christine Ring, by power of attorney
2016-09-13